SMSMED — Scandinavian Medical Solutions A/S Cashflow Statement
0.000.00%
- DKK116.56m
- DKK144.81m
- DKK226.68m
- 66
- 72
- 16
- 49
Annual cashflow statement for Scandinavian Medical Solutions A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | DAS | DAS | DAS | DAS | DAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5.96 | 10.9 | 14.7 | 16.6 | 13.8 |
Depreciation | |||||
Non-Cash Items | -0.146 | -0.333 | -0.022 | -0.575 | -3.68 |
Other Non-Cash Items | |||||
Changes in Working Capital | 3.54 | -6.54 | -25.9 | -28.9 | -13.9 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 9.38 | 4.02 | -10.6 | -8.37 | 3.39 |
Capital Expenditures | — | — | -13.8 | -40.8 | -18.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.029 | -0.269 | -0.011 | 0.954 | 7.34 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.029 | -0.269 | -13.8 | -39.9 | -11.1 |
Financing Cash Flow Items | -2.77 | -8.39 | -3.3 | -0.025 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2.77 | 11.1 | 26.7 | 21.2 | 18.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.58 | 14.8 | 2.36 | -27.3 | 10.3 |